- Home
- SYRE vs LEG Comparison
SYRE vs LEG Comparison
Compare SYRE & LEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- LEG
- Stock Information
- Founded
- SYRE 2013
- LEG 1883
- Country
- SYRE United States
- LEG United States
- Employees
- SYRE 60
- LEG N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- LEG Home Furnishings
- Sector
- SYRE Health Care
- LEG Consumer Discretionary
- Exchange
- SYRE Nasdaq
- LEG Nasdaq
- Market Cap
- SYRE 897.9M
- LEG N/A
- IPO Year
- SYRE 2016
- LEG N/A
- Fundamental
- Price
- SYRE $15.30
- LEG $7.86
- Analyst Decision
- SYRE Strong Buy
- LEG Hold
- Analyst Count
- SYRE 8
- LEG 3
- Target Price
- SYRE $51.50
- LEG $12.00
- AVG Volume (30 Days)
- SYRE 651.5K
- LEG 3.5M
- Earning Date
- SYRE 05-08-2025
- LEG 04-29-2025
- Dividend Yield
- SYRE N/A
- LEG 2.54%
- EPS Growth
- SYRE N/A
- LEG N/A
- EPS
- SYRE N/A
- LEG N/A
- Revenue
- SYRE N/A
- LEG $4,383,600,000.00
- Revenue This Year
- SYRE N/A
- LEG N/A
- Revenue Next Year
- SYRE N/A
- LEG $1.25
- P/E Ratio
- SYRE N/A
- LEG N/A
- Revenue Growth
- SYRE N/A
- LEG N/A
- 52 Week Low
- SYRE $15.26
- LEG $7.74
- 52 Week High
- SYRE $40.84
- LEG $19.33
- Technical
- Relative Strength Index (RSI)
- SYRE 32.29
- LEG 34.02
- Support Level
- SYRE $16.71
- LEG $7.74
- Resistance Level
- SYRE $18.28
- LEG $8.21
- Average True Range (ATR)
- SYRE 1.21
- LEG 0.29
- MACD
- SYRE -0.13
- LEG 0.03
- Stochastic Oscillator
- SYRE 1.29
- LEG 13.79
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.